Founded to Solve a Real Problem in EV Biomanufacturing.
The EV field has extraordinary potential. What it has lacked is infrastructure. We are building it.
Why Did BioThera Solutions Build an EV Biomanufacturing Platform?
BioThera Solutions was founded to address a critical gap in the extracellular vesicle (EV/exosome) field: the absence of scalable, standardized, and reproducible manufacturing required to bring EV technologies — of all kinds — into real-world application. We set out to build the infrastructure that would make the first truly credible EV skincare company possible, and to lay the foundation for everything that comes after it.
Despite growing scientific evidence for EVs as potent biological delivery systems, the industry has struggled to translate laboratory findings into commercially viable, consistently manufactured products. The problem is not the biology — it is the infrastructure.
We are building that infrastructure — and we started where the need is most immediate. The market for exosome-based skincare has exploded in recent years, driven by genuine scientific interest and surging consumer demand. Dermatologists and aesthetic medicine clinicians increasingly want to offer EV-based treatments to their patients. Yet what they find is a market flooded with products making bold claims, backed by inadequate characterization, inconsistent particle concentrations, and little to no regulatory transparency. There is real demand, and a real absence of products that actually meet clinical standards.
BioThera was built to close that gap. We bring genuine biomanufacturing expertise — MISEV2023-compliant characterization, verified particle concentrations, full regulatory compliance — to a space that has been underserved by rigorous science. Our first product, the mPDEV (Exosome) Serum, is our answer to the question dermatologists have been asking: where is the EV product I can actually trust?
Dermocosmetics is where we earn the right to be taken seriously. The platform we are building here is the foundation for everything that follows — including mammalian EV commercialization, regenerative medicine applications, and next-generation drug delivery.
Build scalable EV biomanufacturing platforms — across plant-derived, mammalian, and next-generation EV modalities — to deliver standardized, high-quality extracellular vesicles across consumer and clinical applications.
Starting with dermocosmetics as our commercial validation point, we are establishing the manufacturing infrastructure that the EV field requires to mature.
To be recognized as the biomanufacturing backbone of the EV field — helping advance the standards, reproducibility, and production infrastructure that bring extracellular vesicles from laboratory promise closer to clinical reality.
We are in the early chapters of the EV era. Our ambition is to contribute meaningfully to how this field matures — building the manufacturing foundation that connects consumer health today with regenerative medicine and therapeutic applications tomorrow.
What Principles Guide BioThera Solutions?
Radical Scientific Transparency
We make no claims we cannot substantiate. Every product specification, characterization result, and regulatory status is communicated with precision. Vague language and marketing hyperbole have no place in how we operate.
Uncompromising Excellence
Manufacturing standards, characterization protocols, formulation quality — we apply the same rigor at every stage, regardless of where we are in the development cycle. Quality is built in, not inspected in.
Innovation
The EV space is early. The manufacturing infrastructure needed to make EVs clinically and commercially viable does not yet fully exist — we are building it. That requires genuine scientific creativity and technical courage.
Execution
Ideas in biotech are plentiful. Rigorous, reliable execution is rare. We close the gap between scientific potential and real-world deployment — consistently, on schedule, and to spec.
Ottawa, Ontario, Canada
BioThera Solutions is headquartered in Ottawa, Ontario. Our location provides proximity to regulatory bodies, a growing life sciences ecosystem, and the clinical and research collaborators central to our work.
University of Ottawa — STEM Complex · Ottawa, Ontario
Company Clarification
BioThera Solutions (Canada) is an independent biotechnology firm specializing exclusively in plant-derived extracellular vesicles (EVs). We have no affiliation with Bio-Thera Solutions, Ltd. (China), which focuses on biosimilars and antibody-drug conjugates (ADCs). Our mission is to build the biomanufacturing infrastructure the EV field needs — beginning with plant-derived EVs and scaling toward a full-spectrum EV commercialization platform spanning plant-derived, mammalian, and next-generation vesicle modalities.
BioThera Solutions works exclusively with selected partners.
We selectively engage with dermatology clinics, aesthetic medicine practices, and research collaborators where there is strong scientific and strategic alignment. We are not broadly in market at this time.
Partnership inquiries are reviewed individually.
Inquire About Partnership